Northwest Bancshares’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.69M Sell
55,622
-2,855
-5% -$330K 1.33% 17
2025
Q4
$6.16M Sell
58,477
-7,418
-11% -$696K 1.19% 17
2025
Q3
$5.53M Buy
65,895
+4,084
+7% +$336K 0.92% 28
2025
Q2
$4.89M Buy
61,811
+2,614
+4% +$208K 0.85% 32
2025
Q1
$5.31M Buy
59,197
+2,597
+5% +$242K 0.98% 23
2024
Q4
$5.63M Sell
56,600
-728
-1% -$75.1K 1.04% 21
2024
Q3
$6.51M Sell
57,328
-5,561
-9% -$661K 1.11% 18
2024
Q2
$7.79M Sell
62,889
-2,638
-4% -$340K 1.33% 17
2024
Q1
$8.65M Sell
65,527
-2,785
-4% -$343K 1.36% 10
2023
Q4
$7.45M Buy
68,312
+847
+1% +$87.9K 1.36% 9
2023
Q3
$6.95M Buy
67,465
+500
+0.7% +$53.9K 1.33% 10
2023
Q2
$7.73M Sell
66,965
-554
-0.8% -$62.9K 1.4% 8
2023
Q1
$7.18M Sell
67,519
-862
-1% -$93.1K 1.39% 9
2022
Q4
$7.59M Sell
68,381
-4,302
-6% -$440K 1.52% 8
2022
Q3
$6.26M Sell
72,683
-909
-1% -$81.1K 1.46% 8
2022
Q2
$6.71M Sell
73,592
-2,592
-3% -$230K 1.52% 9
2022
Q1
$6.25M Buy
76,184
+1,262
+2% +$99.5K 1.2% 15
2021
Q4
$5.74M Sell
74,922
-718
-0.9% -$57.2K 1.13% 19
2021
Q3
$5.68M Buy
75,640
+3,661
+5% +$278K 1.29% 13
2021
Q2
$5.6M Buy
71,979
+1,977
+3% +$147K 1.27% 20
2021
Q1
$5.15M Buy
70,002
+8,790
+14% +$648K 1.22% 23
2020
Q4
$4.78M Buy
61,212
+49,755
+434% +$3.81M 1.23% 22
2020
Q3
$907K Sell
11,457
-205
-2% -$16.1K 0.23% 102
2020
Q2
$861K Buy
11,662
+1,948
+20% +$147K 0.23% 102
2020
Q1
$713K Sell
9,714
-878
-8% -$69K 0.35% 64
2019
Q4
$919K Hold
10,592
0.35% 68
2019
Q3
$851K Sell
10,592
-79
-0.7% -$6.33K 0.35% 71
2019
Q2
$854K Buy
10,671
+100
+0.9% +$7.66K 0.36% 70
2019
Q1
$839K Buy
10,571
+87
+0.8% +$6.51K 0.36% 71
2018
Q4
$764K Sell
10,484
-261
-2% -$18.4K 0.37% 70
2018
Q3
$727K Buy
10,745
+314
+3% +$20K 0.32% 78
2018
Q2
$604K Hold
10,431
0.25% 84
2018
Q1
$542K Hold
10,431
0.22% 89
2017
Q4
$560K Buy
+10,431
New +$578K 0.23% 87

Other funds holding MRK

Northwest Bancshares's MRK Position: Q1 2026 in Review

Northwest Bancshares reduced its Merck (MRK) stake by 4.9% in Q1 2026, selling an estimated $330K and leaving 55,622 shares worth $6.69M. The position accounts for 1.33% of the portfolio, ranked #17.

Northwest Bancshares first reported a position in MRK in Q4 2017 and has held it in 34 quarters since. The position peaked at $8.65M in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Northwest Bancshares held 55,622 shares of Merck worth $6.69M as of Q1 2026.
  • Northwest Bancshares sold 2,855 Merck shares in Q1 2026, an estimated $330K.
  • Merck made up 1.33% of Northwest Bancshares's portfolio in Q1 2026, its #17 holding.
  • Northwest Bancshares first reported a position in Merck in Q4 2017 and has held it in 34 quarters since.
  • Northwest Bancshares's Merck position peaked at $8.65M in Q1 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Northwest Bancshares's 13F filing for Q1 2026, filed 12 May 2026.